BALASA DINVERNO & FOLTZ LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BALASA DINVERNO & FOLTZ LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2020$253,000
-22.2%
6,683
-3.4%
0.03%
-5.9%
Q4 2019$325,000
+10.9%
6,917
+0.6%
0.03%0.0%
Q3 2019$293,000
+7.7%
6,875
+1.1%
0.03%
+6.2%
Q2 2019$272,000
-3.5%
6,799
+0.8%
0.03%
-5.9%
Q1 2019$282,000
+7.6%
6,747
-1.7%
0.03%
+3.0%
Q4 2018$262,000
-5.1%
6,8610.0%0.03%
+6.5%
Q3 2018$276,000
-0.4%
6,8610.0%0.03%
-22.5%
Q2 2018$277,000
+3.4%
6,8610.0%0.04%
-2.4%
Q1 2018$268,000
+8.9%
6,861
-1.2%
0.04%
+13.9%
Q4 2017$246,000
-12.8%
6,9420.0%0.04%
-18.2%
Q3 2017$282,000
-5.7%
6,9420.0%0.04%
-10.2%
Q2 2017$299,000
+1.0%
6,942
-1.3%
0.05%
-2.0%
Q1 2017$296,000
+2.8%
7,030
-5.9%
0.05%
+2.0%
Q4 2016$288,000
-10.6%
7,4720.0%0.05%
-16.9%
Q3 2016$322,000
-0.6%
7,4720.0%0.06%
+1.7%
Q2 2016$324,000
+5.5%
7,472
-1.3%
0.06%
+5.5%
Q1 2016$307,000
+0.7%
7,5690.0%0.06%
+7.8%
Q4 2015$305,000
+3.7%
7,569
-1.2%
0.05%
-1.9%
Q3 2015$294,000
-6.7%
7,659
+1.2%
0.05%
+2.0%
Q2 2015$315,000
-10.5%
7,569
-0.8%
0.05%
+2.0%
Q1 2015$352,000
+5.7%
7,627
-2.2%
0.05%
+4.2%
Q4 2014$333,000
-7.0%
7,7960.0%0.05%
-11.1%
Q3 2014$358,000
-14.1%
7,7960.0%0.05%
+12.5%
Q2 2014$417,0000.0%7,7960.0%0.05%
-5.9%
Q1 2014$417,000
-0.5%
7,796
-0.7%
0.05%
-12.1%
Q4 2013$419,000
+5.8%
7,848
-0.5%
0.06%
-12.1%
Q3 2013$396,000
+0.5%
7,8880.0%0.07%
-5.7%
Q2 2013$394,0007,8880.07%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders